Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangling Biopharmaceutical Technology is a biotechnology company based in the Yangling Agricultural High-tech Industry Demonstration Zone in Shaanxi, China. The company specializes in the research, development, and manufacturing of veterinary biological products, with a primary focus on vaccines for livestock. Its portfolio includes essential vaccines for foot-and-mouth disease and classical swine fever, serving the domestic animal health market. The company operates modern production lines that meet national GMP standards for veterinary medicine. Through partnerships with local agricultural universities, it translates research into commercial animal health solutions. Yangling Biopharmaceutical Technology is a key contributor to the regional bio-economy and national livestock disease control efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangling Biopharmaceutical Technology.